Cargando…
Characteristics and Risk Factors of Ultra-High-Risk Patients with Newly Diagnosed Multiple Myeloma
Objective: To investigate the clinical characteristics and risk factors of ultra-high-risk (UHR) patients with newly diagnosed multiple myeloma (MM). Methods: We screened UHR patients with a survival of less than 24 months and we selected patients with a concurrent survival of more than 24 months as...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10146518/ https://www.ncbi.nlm.nih.gov/pubmed/37109052 http://dx.doi.org/10.3390/jpm13040666 |
_version_ | 1785034598887981056 |
---|---|
author | Geng, Chuanying Yang, Guangzhong Zhou, Huixing Wang, Huijuan Li, Yanchen Leng, Yun Zhang, Zhiyao Jian, Yuan Chen, Wenming |
author_facet | Geng, Chuanying Yang, Guangzhong Zhou, Huixing Wang, Huijuan Li, Yanchen Leng, Yun Zhang, Zhiyao Jian, Yuan Chen, Wenming |
author_sort | Geng, Chuanying |
collection | PubMed |
description | Objective: To investigate the clinical characteristics and risk factors of ultra-high-risk (UHR) patients with newly diagnosed multiple myeloma (MM). Methods: We screened UHR patients with a survival of less than 24 months and we selected patients with a concurrent survival of more than 24 months as a control group. We retrospectively analyzed the clinical characteristics of UHR patients with newly diagnosed MM and screened related risk factors. Results: In total we analyzed 477 patients, which included 121 (25.4%) UHR patients and 356 (74.6%) control patients. Median overall survival (OS) and progression-free survival (PFS) of UHR patients was 10.5 months (7.5–13.5 months) and 6.3 months (5.4–7.2 months), respectively. Univariate logistic regression analysis showed that age > 65 years, hemoglobin (HGB) < 100 g/L, lactate dehydrogenase (LDH) > 250 U/L, serum creatinine (SCr) > 2 mg/dL, corrected serum calcium (CsCa) > 2.75 mmol/L, B-type natriuretic peptide (BNP) or N-terminal prohormone BNP (NT-proBNP) > 2 upper limit of normal (ULN), high-risk cytogenetics, Barthel index score, and International Staging System (ISS) stage III were associated with UHR MM. In a multivariate analysis, age > 65 years, LDH > 250 U/L, CsCa > 2.75 mmol/L, BNP or NT-proBNP > 2 ULN, high-risk cytogenetics, and Barthel index score were independent risk factors for UHR MM. Moreover, UHR patients had a worse response rate than control patients. Conclusion: Our study highlighted the characteristics of UHR MM patients and suggested that the combination of organ insufficiency and highly malignant myeloma cells resulted in poor outcomes of patients with UHR MM. |
format | Online Article Text |
id | pubmed-10146518 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-101465182023-04-29 Characteristics and Risk Factors of Ultra-High-Risk Patients with Newly Diagnosed Multiple Myeloma Geng, Chuanying Yang, Guangzhong Zhou, Huixing Wang, Huijuan Li, Yanchen Leng, Yun Zhang, Zhiyao Jian, Yuan Chen, Wenming J Pers Med Article Objective: To investigate the clinical characteristics and risk factors of ultra-high-risk (UHR) patients with newly diagnosed multiple myeloma (MM). Methods: We screened UHR patients with a survival of less than 24 months and we selected patients with a concurrent survival of more than 24 months as a control group. We retrospectively analyzed the clinical characteristics of UHR patients with newly diagnosed MM and screened related risk factors. Results: In total we analyzed 477 patients, which included 121 (25.4%) UHR patients and 356 (74.6%) control patients. Median overall survival (OS) and progression-free survival (PFS) of UHR patients was 10.5 months (7.5–13.5 months) and 6.3 months (5.4–7.2 months), respectively. Univariate logistic regression analysis showed that age > 65 years, hemoglobin (HGB) < 100 g/L, lactate dehydrogenase (LDH) > 250 U/L, serum creatinine (SCr) > 2 mg/dL, corrected serum calcium (CsCa) > 2.75 mmol/L, B-type natriuretic peptide (BNP) or N-terminal prohormone BNP (NT-proBNP) > 2 upper limit of normal (ULN), high-risk cytogenetics, Barthel index score, and International Staging System (ISS) stage III were associated with UHR MM. In a multivariate analysis, age > 65 years, LDH > 250 U/L, CsCa > 2.75 mmol/L, BNP or NT-proBNP > 2 ULN, high-risk cytogenetics, and Barthel index score were independent risk factors for UHR MM. Moreover, UHR patients had a worse response rate than control patients. Conclusion: Our study highlighted the characteristics of UHR MM patients and suggested that the combination of organ insufficiency and highly malignant myeloma cells resulted in poor outcomes of patients with UHR MM. MDPI 2023-04-14 /pmc/articles/PMC10146518/ /pubmed/37109052 http://dx.doi.org/10.3390/jpm13040666 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Geng, Chuanying Yang, Guangzhong Zhou, Huixing Wang, Huijuan Li, Yanchen Leng, Yun Zhang, Zhiyao Jian, Yuan Chen, Wenming Characteristics and Risk Factors of Ultra-High-Risk Patients with Newly Diagnosed Multiple Myeloma |
title | Characteristics and Risk Factors of Ultra-High-Risk Patients with Newly Diagnosed Multiple Myeloma |
title_full | Characteristics and Risk Factors of Ultra-High-Risk Patients with Newly Diagnosed Multiple Myeloma |
title_fullStr | Characteristics and Risk Factors of Ultra-High-Risk Patients with Newly Diagnosed Multiple Myeloma |
title_full_unstemmed | Characteristics and Risk Factors of Ultra-High-Risk Patients with Newly Diagnosed Multiple Myeloma |
title_short | Characteristics and Risk Factors of Ultra-High-Risk Patients with Newly Diagnosed Multiple Myeloma |
title_sort | characteristics and risk factors of ultra-high-risk patients with newly diagnosed multiple myeloma |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10146518/ https://www.ncbi.nlm.nih.gov/pubmed/37109052 http://dx.doi.org/10.3390/jpm13040666 |
work_keys_str_mv | AT gengchuanying characteristicsandriskfactorsofultrahighriskpatientswithnewlydiagnosedmultiplemyeloma AT yangguangzhong characteristicsandriskfactorsofultrahighriskpatientswithnewlydiagnosedmultiplemyeloma AT zhouhuixing characteristicsandriskfactorsofultrahighriskpatientswithnewlydiagnosedmultiplemyeloma AT wanghuijuan characteristicsandriskfactorsofultrahighriskpatientswithnewlydiagnosedmultiplemyeloma AT liyanchen characteristicsandriskfactorsofultrahighriskpatientswithnewlydiagnosedmultiplemyeloma AT lengyun characteristicsandriskfactorsofultrahighriskpatientswithnewlydiagnosedmultiplemyeloma AT zhangzhiyao characteristicsandriskfactorsofultrahighriskpatientswithnewlydiagnosedmultiplemyeloma AT jianyuan characteristicsandriskfactorsofultrahighriskpatientswithnewlydiagnosedmultiplemyeloma AT chenwenming characteristicsandriskfactorsofultrahighriskpatientswithnewlydiagnosedmultiplemyeloma |